Turn Therapeutics (TTRX) Share-based Compensation (2024 - 2026)

Turn Therapeutics' Share-based Compensation history runs 3 years deep, the most recent figure standing at $1.2 million for Q1 2026.

• In Q1 2026, Share-based Compensation rose 1466.64% year-over-year to $1.2 million; the TTM figure through Mar 2026 stood at $1.2 million (changed N/A YoY), while the FY2025 annual figure was $1.4 million, up 296.79% from the prior year.
• Share-based Compensation for Q1 2026 stood at $1.2 million, up from $256380.0 in the prior quarter.
• The five-year high for Share-based Compensation was $1.2 million in Q1 2026, with the low at $37813.0 in Q4 2024.
• The 3-year median for Share-based Compensation is $256380.0 (2025), against an average of $375228.0.
• The sharpest annual moves came in 2025 and 2026: Share-based Compensation jumped 578.02% in 2025, then jumped 1466.64% in 2026.
• Turn Therapeutics' Share-based Compensation stood at $37813.0 in 2024, then surged by 578.02% to $256380.0 in 2025, then soared by 368.06% to $1.2 million in 2026.
• Business Quant data shows TTRX's Share-based Compensation at $1.2 million in Q1 2026, $256380.0 in Q4 2025, and $305350.0 in Q3 2025.